retatrutide diabetes RETATRUTIDE: A Medication for and Weight Loss Survodutide vs. Retatrutide for Weight
Description
BMJ, 384, bmj-2023-076410
The MHRA regulates the approval of new medicines in Great Britain following the UK's departure from the European Union, whilst the EMA retains responsibility for authorisation across EU member states
Condition varies by listing
Xu Y, Jones JE, Kohno D
Make it count
Harvard researchers found diabetic users were four times more likely to develop the condition, while non-diabetic users faced a sevenfold increased risk
